Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants

Figure 3

Boxplot graph representing changes in central retinal thickness (CRT), number of hyperreflective foci (HF), and number of hard exudates (HE) after anti-VEGF therapy (VEGF group) or dexamethasone implantation (DEX group) in patients with diabetic macular edema (DME). Figure shows the difference in change in (a) CRT in μm (b) number of HF, and (c) number of HE for the VEGF and DEX group at baseline versus 15 or 30 days after the injection.

(a)

(b)

(c)